MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plo, I.
Right arrow Articles by Lautier, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plo, I.
Right arrow Articles by Lautier, D.

Vol. 62, Issue 2, 304-312, August 2002

Influence of Ceramide Metabolism on P-Glycoprotein Function in Immature Acute Myeloid Leukemia KG1a Cells

Isabelle Plo, Gustav Lehne, Karen Johanne Beckstrøm, Nicolas Maestre, Ali Bettaïeb, Guy Laurent, and Dominique Lautier

Institut National de la Santé et de la Recherche Médicale (INSERM) E9910, Institut Claudius Régaud, Toulouse, France (I.P., N.M., G.La., D.L.); Department of Clinical Pharmacology, Rikshospitalet University Hospital, Oslo, Norway (G.Le., K.J.B.); L'École Pratique des Hautes Études/INSERM U517, Mort Cellulaire et Cancer, UFR de Pharmacie, Dijon, France (A.B.); and Service d'Hématologie, Centre Hospitalier Universitaire Purpan, Toulouse, France (G.La.)

Previous studies have emphasized the role of glucosylceramide (Glu-Cer) synthase in multidrug resistance (MDR) regulation. However, the mechanism by which the inhibition of this enzyme results in increased drug retention and cytotoxicity remains unclear. In this study, we investigated the respective role of ceramide (Cer) accumulation and Glu-Cer derivatives depletion in MDR reversal effect of 1-phenyl-2-decanoylamino-3-morpholino-1-propanolol (PDMP), a Glu-Cer synthase inhibitor. We show here that treatment with PDMP resulted in increased rhodamine 123 (Rh123) retention and potent chemosensitization of P-glycoprotein (P-gp)-expressing cells, including KG1a cells, KG1a/200 cells, K562/138 cells, and K562/mdr-1 cells. Metabolic studies revealed that PDMP induced not only time-dependent Cer accumulation but also reduction of all glycosylated forms of Cer, including Glu-Cer, lactosylceramide (Lac-Cer), monosialo ganglioside (GM3) and disialo ganglioside (GD3). The influence of these metabolites on P-gp function was investigated by measuring Rh123 retention in PDMP-treated cells. P-gp function was found to be stimulated only by the addition of gangliosides in all resistant cell lines, whereas Glu-Cer, Lac-Cer, and Cer had no effect. Moreover, in KG1a/200 cells, GD3 and, to a lesser extent, GM3 were found to phosphorylate P-gp on serine residues. Altogether, these results suggest that, at least in leukemic cells, gangliosides depletion accounts for PDMP-mediated MDR reversal effect, and that gangliosides are important P-gp regulators perhaps through their capacity to modulate P-gp phosphorylation.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. F. De Rosa, C. Ackerley, B. Wang, S. Ito, D. M. Clarke, and C. Lingwood
Inhibition of Multidrug Resistance by AdamantylGb3, a Globotriaosylceramide Analog
J. Biol. Chem., February 22, 2008; 283(8): 4501 - 4511.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A.-J. Dijkhuis, K. Klappe, W. Kamps, H. Sietsma, and J. W. Kok
Gangliosides do not affect ABC transporter function in human neuroblastoma cells
J. Lipid Res., June 1, 2006; 47(6): 1187 - 1195.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Gouaze, Y.-Y. Liu, C. S. Prickett, J. Y. Yu, A. E. Giuliano, and M. C. Cabot
Glucosylceramide Synthase Blockade Down-Regulates P-Glycoprotein and Resensitizes Multidrug-Resistant Breast Cancer Cells to Anticancer Drugs
Cancer Res., May 1, 2005; 65(9): 3861 - 3867.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
V. Gouaze, J. Y. Yu, R. J. Bleicher, T.-Y. Han, Y.-Y. Liu, H. Wang, M. M. Gottesman, A. Bitterman, A. E. Giuliano, and M. C. Cabot
Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy
Mol. Cancer Ther., May 1, 2004; 3(5): 633 - 640.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Grazide, A.-D. Terrisse, S. Lerouge, G. Laurent, and J.-P. Jaffrezou
Cytoprotective Effect of Glucosylceramide Synthase Inhibition against Daunorubicin-induced Apoptosis in Human Leukemic Cell Lines
J. Biol. Chem., April 30, 2004; 279(18): 18256 - 18261.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. De Rosa, D. Sillence, C. Ackerley, and C. Lingwood
Role of Multiple Drug Resistance Protein 1 in Neutral but Not Acidic Glycosphingolipid Biosynthesis
J. Biol. Chem., February 27, 2004; 279(9): 7867 - 7876.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics